188 related articles for article (PubMed ID: 37528249)
21. Micro-inflammation characterized by disturbed Treg/Teff balance with increasing sIL-2R in patients with type 2 diabetes.
Cai B; Zhang J; Zhang M; Li L; Feng W; An Z; Wang L
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):214-9. PubMed ID: 23595796
[TBL] [Abstract][Full Text] [Related]
22. In vivo CD3+CD25+ lymphocyte subpopulation is down-regulated without increased serum-soluble interleukin-2 receptor (sIL-2R) by gonadotropin releasing hormone agonist (GnRH-a).
Ho HN; Wu MY; Chen HF; Chao KH; Yang YS; Huang SC; Lee TY; Gill TJ
Am J Reprod Immunol; 1995 Jan; 33(1):134-9. PubMed ID: 7619228
[TBL] [Abstract][Full Text] [Related]
23. Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis.
Guo RH; Cheng H; Zhang XY; Yu Z; Wang GH; Hao SY; Gao XP; Wen HY
Front Pharmacol; 2022; 13():986199. PubMed ID: 36408259
[No Abstract] [Full Text] [Related]
24. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.
Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Tura S; Papa G
Cancer; 1994 Sep; 74(6):1792-800. PubMed ID: 8082082
[TBL] [Abstract][Full Text] [Related]
25. Imbalance of peripheral blood Th17/Treg increases neutrophil-to-lymphocyte ratio in patients with dermatomyositis.
Zhang Z; Pang J; Li Y; Zuo Y; Cui X; Xu H
Am J Transl Res; 2023; 15(10):6106-6114. PubMed ID: 37969179
[TBL] [Abstract][Full Text] [Related]
26. Reduction of peripheral regulatory T cells in active rheumatoid arthritis patients with coronary artery disease.
Wang Y; Su R; Li B; Guo Q; Hu F; Yu X; Ma M; Wang L; Gao C; Li X; Wang C
BMC Immunol; 2021 Dec; 22(1):76. PubMed ID: 34915859
[TBL] [Abstract][Full Text] [Related]
27. Clinical and immunological characteristics and prognosis of patients with autoantibody negative dermatomyositis: a case control study.
Xing X; Gan Y; Mo W; Zhang J; Wang N; Zhang K; Ma K; Zhang L; Ma L; Lu D; Li Y; He J
Clin Rheumatol; 2024 Mar; 43(3):1145-1154. PubMed ID: 38326675
[TBL] [Abstract][Full Text] [Related]
28. Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy.
Chen W; Zhang Q; Li M; Huang G; Guo L; Chen Z; Ding Q; Gu Y
Clin Chim Acta; 2023 May; 545():117372. PubMed ID: 37127231
[TBL] [Abstract][Full Text] [Related]
29. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change.
Hofmann B; Nishanian P; Fahey JL; Esmail I; Jackson AL; Detels R; Cumberland W
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):212-24. PubMed ID: 1680589
[TBL] [Abstract][Full Text] [Related]
30. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
[TBL] [Abstract][Full Text] [Related]
31. Reduced activated regulatory T cells and imbalance of Th17/activated Treg cells marks renal involvement in ANCA-associated vasculitis.
Wang Y; Zhang S; Zhang N; Feng M; Liang Z; Zhao X; Gao C; Qin Y; Wu Y; Liu G; Zhao J; Guo H; Luo J
Mol Immunol; 2020 Feb; 118():19-29. PubMed ID: 31837507
[TBL] [Abstract][Full Text] [Related]
32. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
33. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.
Mariotti S; Caturegli P; Barbesino G; Marinò M; Del Prete GF; Chiovato L; Tonacchera M; De Carli M; Pinchera A
Clin Endocrinol (Oxf); 1992 Nov; 37(5):415-22. PubMed ID: 1486691
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.
Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268
[TBL] [Abstract][Full Text] [Related]
35. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
Steen VD; Engel EE; Charley MR; Medsger TA
J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
[TBL] [Abstract][Full Text] [Related]
36. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
Vonderheid EC; Zhang Q; Lessin SR; Polansky M; Abrams JT; Bigler RD; Wasik MA
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):207-20. PubMed ID: 9486676
[TBL] [Abstract][Full Text] [Related]
37. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.
Wang L; Wang JH; Liu WJ; Wang WD; Wang H; Chen XQ; Geng QR; Lu Y; Xia ZJ
Ann Hematol; 2017 Dec; 96(12):2079-2088. PubMed ID: 28871325
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of soluble interleukin-2 receptor measurement in patients with idiopathic retroperitoneal fibrosis.
Kharagjitsing HHS; Hendriksz TR; Fouraux MA; van Gelder T; van Bommel EFH
Int Urol Nephrol; 2022 Oct; 54(10):2663-2671. PubMed ID: 35359217
[TBL] [Abstract][Full Text] [Related]
39. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
Raziuddin S; al-Janadi MA; al-Wabel AA
J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
[TBL] [Abstract][Full Text] [Related]
40. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
